Envoy Medical, Inc. COCH
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -10.04% | -18.37% | -14.24% | -3.40% | -55.91% |
| Total Depreciation and Amortization | 24.69% | 57.00% | 74.57% | 56.07% | 58.82% |
| Total Amortization of Deferred Charges | -6.69% | -7.81% | -7.93% | -30.83% | -12.27% |
| Total Other Non-Cash Items | -55.95% | 58.65% | 8.22% | 8.80% | 157.34% |
| Change in Net Operating Assets | -144.72% | -89.30% | 388.24% | 113.34% | 143.44% |
| Cash from Operations | -35.44% | -27.68% | -1.40% | 26.65% | 21.61% |
| Capital Expenditure | -102.27% | 80.27% | 81.73% | 134.33% | 91.04% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -102.27% | 80.27% | 81.73% | 134.33% | 91.04% |
| Total Debt Issued | -100.00% | -75.00% | -50.00% | 0.00% | 114.29% |
| Total Debt Repaid | -1.50% | -1.12% | -1.20% | 25.04% | 19.96% |
| Issuance of Common Stock | 10,631.98% | 58,780.95% | 306.53% | 70.42% | -80.80% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 100.00% | 83.42% | 25.62% | -32.79% | -- |
| Other Financing Activities | -96.36% | -96.36% | 25.67% | 254.61% | -84.53% |
| Cash from Financing | 84.91% | 134.64% | -17.65% | 23.49% | -14.90% |
| Foreign Exchange rate Adjustments | -400.00% | -300.00% | 160.00% | 120.00% | 120.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 306.55% | 5,347.81% | -237.97% | 93.00% | 110.97% |